Skip to main content
EP

Epion Therapeutics

Burlington, United States
Last funding
$32.0M
Series ASep 2022

Epion is developing a minimally invasive treatment for an ectatic corneal disease.

Backed byGlobal Health Investment Fund (GHIF)

About Epion Therapeutics

How much funding has Epion Therapeutics raised?

Epion Therapeutics has raised $32.0M in total funding. The most recent round was Series A. The last funding was announced in September 2022.

Who are Epion Therapeutics's investors?

Epion Therapeutics's investors include Global Health Investment Fund (GHIF).

Where is Epion Therapeutics headquartered?

Epion Therapeutics is headquartered in Burlington, United States.

What does Epion Therapeutics do?

Epion is developing a minimally invasive treatment for an ectatic corneal disease.

What stage is Epion Therapeutics at?

Epion Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Epion Therapeutics — Funding & Investors." VCBacked, September 30, 2022, https://www.vcbacked.co/company/epion-therapeutics. Accessed November 14, 2026.
APA
VCBacked. (2022). Epion Therapeutics — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/epion-therapeutics
Wikipedia (cite web)
{{cite web |title=Epion Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/epion-therapeutics |website=VCBacked |access-date=November 14, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Epion Therapeutics? Request a listing update

Founder contacts
m***@epiontx.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →